Novel tumortropic ester derivatives of 99mtc(v) mesodimercapto succinic acid with low affinity for bone tissue

Nuclear Medicine Communications

Volumn 24, Issue 11, 2003, Pages 1175-1183

  Seifert, S ^a   Syhre, R ^a   Spies, H ^a   Johannsen, B ^a  

^a INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

Author keywords

99mTc DMSA ester complexes; Age dependent bone uptake; Tumour uptake

Indexed keywords

ESTER DERIVATIVE; SUCCIMER TC 99M;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE STRUCTURE; BONE TISSUE; COLON CARCINOMA; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG SCREENING; DRUG SPECIFICITY; DRUG UPTAKE; HUMAN; HUMAN CELL; KIDNEY FUNCTION; LIVER METABOLISM; MOUSE; NONHUMAN; NUDE MOUSE; SKULL; SQUAMOUS CELL CARCINOMA;

AGING; ANIMALS; BONE AND BONES; CARCINOMA; ESTERS; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; RATS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TISSUE DISTRIBUTION;

EID: 5444238006     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200311000-00008     Document Type: Article

References (33)

1. Yokoyama A, Hata N, Saji N, et al. Chemically designed Tc-99m radiopharmaceuticals for the tumor diagnosis: Tc-99m DMSA. J Nucl Med 1981; 22: 69 (abstract).
2. Hata N, Masuda H, Yokoyama A, Takanaka H. Tumor accumulation of Tc(V)-dimercaptosuccinate: a phosphate like Tc(V) anion. J Pharm Dyn 1983; 6: 35 (abstract).
3. Ohta H, Endo K, Fujita T, et al. Imaging of soft tissue tumors with Tc(V)-99m dimercaptosuccinic acid. A new tumor-seeking agent. Clin Nucl Med 1984; 9: 568-573.
4. Watkinson JC, Clarke SE, Shaheen OH. An evaluation of the uptake of technetium-99m (V) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck. Clin Otolaryngol 1987; 12: 405-411.
5. 99mTc(V)-DMS in lung metastasis of osteosarcoma. Ann Nucl Med 1989; 3: 37-40.
6. Kobayashi H, Sakahara H, Hosono M, et al. Soft-tissue tumors: diagnosis with Tc-99m(V) dimercaptosuccinic acid scintigraphy. Radiology 1994; 190: 277-280.
7. Hirano T, Otake H, Yoshida I, Endo K. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA. J Nucl Med 1995; 36: 202-207.
8. m-DMSA imaging in patients with bone metastases. Nucl Med Commun 1997; 18: 907-914.
9. Shinozaki T, Hirano T, Watanabe H, Aoki J, Takagishi K. Tc-99m(V) dimercaptosuccinic acid scintigraphy for bone and soft tissue lesions. Clin Nucl Med 2000; 25: 637-640.
10. Sahin M, Basoglu T, Albayrak S, Canbaz F, Yapici O. Pentavalent technetium-99m DMSA uptake in pseudofractures of osteomalacia. Clin Nucl Med 2001; 26: 62-64.
11. Knapp Jr FF, Beets AL, Guhlke S, et al. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res 1997; 17: 1783-1795.
12. Blower PJ, Lam ASK, O'Doherty MJ, Kettle AG, Coakley AJ, Knapp Jr FF. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur J Nucl Med 1998; 25: 613-621.
13. Ercan MT, Caglar M. Therapeutic radiopharmaceuticals. Curr Pharm Des 200l; 6: 1085-1121.
14. 99mTc-dimercaptosuccinate complex as a tumor imaging agent. Int J Nucl Med Biol 1985; 12: 273-279.
15. m(V) DMSA in squamous carcinoma: a comparative study in humans and in an animal tumour model. Nucl Med Commun 1990; 11: 547-555.
16. Watkinson JC, Allen SJ, Laws DE, Lazarus CR, Maisey MN, Clarke SE. The pharmacokinetics and biodistribution of technetium-99m(V)dimercaptosuccinic acid in an animal tumor model. J Nucl Med 1991; 32: 1235-1238.
17. Lam ASK, Puncher MR, Blower PJ. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid. Eur J Nucl Med 1996; 23: 1575-1582.
18. Horiuchi K, Saji H, Yokoyama A. Tc(V)-DMS tumor localization mechanism: a pH-sensitive Tc(V)-DMS-enhanced target/nontarget ratio by glucose-mediated acidosis. Nucl Med Biol 1998; 25: 549-555.
19. Wulfrank DA, Schelstraete KH, Small F, Fallais CJ. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP. Clin Nucl Med 1989; 14: 588-593.
20. Kao CH, Wang SJ, Wey SP, Shen LH, Ting G, Yeh SH. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs. Eur J Nucl Med 1992; 19: 890-893.
21. Kobayashi H, Kotoura Y, Hosono M, et al. Diagnostic value of Tc-99m(V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy. Clin Nucl Med 1995; 20: 361-364.
22. 99mTc-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions. Nucl Med Commun 2000; 21: 251-258.
23. 99mTc(V)-DMSA scintigraphy in patients with osteomalacia and primary hyperparathyroidism. Nucl Med Commun 2000; 21: 181-185.
24. Horiuchi-Suzuki K, Fukuda S, Konno A, Fukuda Y, Kobayashi H, Saji H. Differential roles of osteotropic Tc-bisphosphonates (Tc-BP) and Tc(V)-DMS in biological and pathological animal models and bone cell culture. Eur J Nucl Med 2001; 28: 1174 (abstract).
25. 99mTc(V)-DMS, a pathological bone diagnostic agent for differentiation of cancerous bone metastases: from cellular to animal model studies. J Nucl Med 2002; 43: 280P (abstract).
26. Shukla SK, Atzei G, Agiro G, et al. A study of the solution chemistry of different dimercaptosuccinic (DMSA) complexes formed with Tc-99m in order to find the optimal formulation for tumor diagnosis and systemic therapy with DMSA radiopharmaceuticals respectively of Tc-99m (V) and Re-188 (V). In: Nicolini M, Mazzi U, eds. Technetium, rhenium and other metals in chemistry and nuclear medicine, 6. Padova: SGEDITORIALI, 2002: 669-671.
27. 99mTc ester complexes by enzymatic methods in comparison to in vivo metabolism and biodistribution in rats. Annual Report 1994, FZR-73, 133-139.
28. Seifert S, Syhre R, Spies H, Johannsen B. Enzymatic cleavage of technetium and rhenium complexes with DMSA ester ligands. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and rhenium in chemistry and nuclear medicine, 4. Padova: SGEDITORIALI, 1995: 437-440.
29. Seifert S, Hoepping A, Klostermann K, Spies H, Johannsen B. Preparation and characterization of novel mixed-ligand oxorhenium(V) and oxotechnetium(V) complexes bearing up to four ester groups. Appl Radiat Isot 1997; 48: 943-948.
30. Seifert S, Syhre R, Spies H, Johannsen B. Enzymatic hydrolysis of ester groups of mixed-ligand oxorhenium(V) and oxotechnetium(V) complexes. Appl Radiat Isot 1997; 48: 1051-1057.
31. Seifert S, Syhre R, Spies H, Johannsen B. Preparation, characterization and enzymatic hydrolysis of mixed ligand Re/Tc complexes with DMSA and DMS ethyl esters. Annual Report 1994, FZR-73, 38-42.
32. 99mTc DMSA: uptake into a variety of human rhabdomyosarcoma xenografts. In Vivo 1997; 11: 45-50.
33. Blower PJ, Singh J, Clarke SE. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med 1991; 32: 845-849.